Kosztin A - Search Results

1

Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience.

Schwertner WR, Behon A, Merkel ED, Tokodi M, Kovács A, Zima E, Osztheimer I, Molnár L, Király Á, Papp R, Gellér L, Kuthi L, Veres B, Kosztin A, Merkely B. Schwertner WR, et al. Among authors: kosztin a. Europace. 2021 Aug 6;23(8):1310-1318. doi: 10.1093/europace/euab059. Europace. 2021. PMID: 34037220 Free PMC article.

2

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.

Kutyifa V, Geller L, Bogyi P, Zima E, Aktas MK, Ozcan EE, Becker D, Nagy VK, Kosztin A, Szilagyi S, Merkely B. Kutyifa V, et al. Among authors: kosztin a. Eur J Heart Fail. 2014 Dec;16(12):1323-30. doi: 10.1002/ejhf.185. Epub 2014 Nov 7. Eur J Heart Fail. 2014. PMID: 25379962 Free PMC article.

3

Signaling via PI3K/FOXO1A pathway modulates formation and survival of human embryonic stem cell-derived endothelial cells.

Merkely B, Gara E, Lendvai Z, Skopál J, Leja T, Zhou W, Kosztin A, Várady G, Mioulane M, Bagyura Z, Németh T, Harding SE, Földes G. Merkely B, et al. Among authors: kosztin a. Stem Cells Dev. 2015 Apr 1;24(7):869-78. doi: 10.1089/scd.2014.0247. Epub 2014 Dec 22. Stem Cells Dev. 2015. PMID: 25387407 Free PMC article.

4

Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.

Kosztin A, Kutyifa V, Nagy VK, Geller L, Zima E, Molnar L, Szilagyi S, Ozcan EE, Szeplaki G, Merkely B. Kosztin A, et al. Europace. 2016 Apr;18(4):550-9. doi: 10.1093/europace/euv117. Epub 2015 Jun 27. Europace. 2016. PMID: 26116830 Free PMC article.

5

Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients.

Nagy VK, Széplaki G, Apor A, Kutyifa V, Kovács A, Kosztin A, Becker D, Boros AM, Gellér L, Merkely B. Nagy VK, et al. Among authors: kosztin a. PLoS One. 2015 Dec 23;10(12):e0143907. doi: 10.1371/journal.pone.0143907. eCollection 2015. PLoS One. 2015. PMID: 26700308 Free PMC article.

6

Impact of CT-apelin and NT-proBNP on identifying non-responders to cardiac resynchronization therapy.

Kosztin A, Széplaki G, Kovács A, Földes G, Szokodi I, Vivien Nagy K, Kutyifa V, Fórizs É, Végh EM, Gellér L, Becker D, Aradi D, Merkely B. Kosztin A, et al. Biomarkers. 2017 May-Jun;22(3-4):279-286. doi: 10.1080/1354750X.2016.1217931. Epub 2016 Aug 12. Biomarkers. 2017. PMID: 27471876 Free article.

7

Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure.

Széplaki G, Boros AM, Szilágyi S, Osztheimer I, Jenei Z, Kosztin A, Nagy KV, Karády J, Molnár L, Tahin T, Zima E, Gellér L, Prohászka Z, Merkely B. Széplaki G, et al. Among authors: kosztin a. Inflamm Res. 2016 Dec;65(12):933-940. doi: 10.1007/s00011-016-0976-4. Epub 2016 Aug 4. Inflamm Res. 2016. PMID: 27492980

8

Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial.

Merkely B, Kosztin A, Roka A, Geller L, Zima E, Kovacs A, Boros AM, Klein H, Wranicz JK, Hindricks G, Clemens M, Duray GZ, Moss AJ, Goldenberg I, Kutyifa V. Merkely B, et al. Among authors: kosztin a. Europace. 2017 Sep 1;19(9):1549-1555. doi: 10.1093/europace/euw193. Europace. 2017. PMID: 28339581 Free PMC article. Clinical Trial.

9

Quantification of the relative contribution of the different right ventricular wall motion components to right ventricular ejection fraction: the ReVISION method.

Lakatos B, Tősér Z, Tokodi M, Doronina A, Kosztin A, Muraru D, Badano LP, Kovács A, Merkely B. Lakatos B, et al. Among authors: kosztin a. Cardiovasc Ultrasound. 2017 Mar 27;15(1):8. doi: 10.1186/s12947-017-0100-0. Cardiovasc Ultrasound. 2017. PMID: 28347344 Free PMC article.

10

Clinical presentation at first heart failure hospitalization does not predict recurrent heart failure admission.

Kosztin A, Costa J, Moss AJ, Biton Y, Nagy VK, Solomon SD, Geller L, McNitt S, Polonsky B, Merkely B, Kutyifa V. Kosztin A, et al. ESC Heart Fail. 2017 Nov;4(4):520-526. doi: 10.1002/ehf2.12157. Epub 2017 Jun 17. ESC Heart Fail. 2017. PMID: 28960867 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters